CIPLA LIMITED |
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 1’346 INR | -0.12% |
|
-3.65% | +7.98% |
Kurzporträt
Der Nettoumsatz nach Einnahmequellen verteilt sich auf den Verkauf von Produkten (96,9%) und Dienstleistungen (3,1%).
Der Nettoumsatz verteilt sich geographisch wie folgt: Indien (39,4%), die Vereinigten Staaten (18,5%), Südafrika (17%) und andere (25,1%).
Mitarbeiterzahl: 32 323
Umsatz nach Geschäftsbereich
| INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
Pharmaceuticals
96,7
%
| 213 513 | 98,1 % | 219 994 | 96,7 % | +3.04% |
New Ventures
4,6
%
| 5 315 | 2,4 % | 10 548 | 4,6 % | +98.46% |
Inter Segment
-1,3
%
| -1 194 | -0,5 % | -3 012 | -1,3 % | +152.13% |
Umsatz je Region
| INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
India
43,4
%
| 98 275 | 45,2 % | 98 687 | 43,4 % | +0.42% |
United States
26,0
%
| 44 314 | 20,4 % | 59 087 | 26,0 % | +33.34% |
Rest of the World
20,4
%
| 48 715 | 22,4 % | 46 407 | 20,4 % | -4.74% |
South Africa
10,3
%
| 26 330 | 12,1 % | 23 351 | 10,3 % | -11.31% |
Manager
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Umang Vohra
CEO | Chief Executive Officer | 52 | 01.10.15 |
Ashish Adukia
DFI | Director of Finance/CFO | - | 16.08.22 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.86 |
| Chief Tech/Sci/R&D Officer | - | 01.01.20 | |
Jaideep Gogtay
CTO | Chief Tech/Sci/R&D Officer | 58 | 01.09.94 |
Rajendra Chopra
CMP | Compliance Officer | - | 09.02.17 |
| Director/Board Member | 83 | 15.08.77 | |
Dinesh Jain
PRN | Corporate Officer/Principal | - | 09.04.12 |
Deepak Viegas
AUD | Comptroller/Controller/Auditor | - | 01.02.17 |
Raju Mistry
HRO | Human Resources Officer | 60 | 01.04.19 |
Aufsichtsräte
| Aufsichtsräte | Titel | Alter | Seit |
|---|---|---|---|
Ashok K. Sinha
BRD | Director/Board Member | 72 | 16.07.13 |
| Chairman | 87 | 21.07.72 | |
| Director/Board Member | 83 | 15.08.77 | |
| Director/Board Member | 70 | 25.07.14 | |
Umang Vohra
CEO | Chief Executive Officer | 52 | 01.10.15 |
Punita Lal
BRD | Director/Board Member | 60 | 13.11.14 |
| Director/Board Member | 67 | 12.11.10 | |
Robert Stewart
BRD | Director/Board Member | 56 | 14.05.21 |
| Director/Board Member | 69 | 30.06.21 | |
| Director/Board Member | 48 | - |
Anteilsklasse
| Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
|---|---|---|---|---|---|
| Aktie A | 1 | 807 394 968 | 520 684 537 ( 64,49 %) | 0 | 64,49 % |
Unternehmensbesitz
| Name | Aktien | % | Bewertung |
|---|---|---|---|
| 1 869 170 684 | 51,18% | 25 252 496 $ |
Unternehmenskontakt
Cipla Ltd.
Cipla House, Peninsula Business Park Ganpatrao Kadam Marg
400013, Mumbai
+91 22 2482 6000
http://www.cipla.com
Konzerngesellschaften
| Name | Kategorie und Branche |
|---|---|
Meditab Specialities Pvt Ltd.
 Meditab Specialities Pvt Ltd. Pharmaceuticals: MajorHealth Technology Meditab Specialities Pvt Ltd. provides pharmaceutical services. Its specialized in manufacturing facilities,approved by W.H.O. to manufacture dosage forms like Tablets, Capsules, Inhalers, Powders,etc they are contributing to various Pharmacopoeias like EP, BP and USP. The company is headquartered at India. |
Pharmaceuticals: Major
|
InvaGen Pharmaceuticals, Inc.
 InvaGen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology InvaGen Pharmaceuticals, Inc. manufactures and distributes generic prescription medicines. It develops and markets generic pharmaceuticals with focus on therapeutic areas including, cardiovascular, anti-infective, CNS, anti-inflammatory, anti-diabetic and anti-depressants. The company was founded by Sudhakar Vidiyala, Madhava U. Reddy and Amar Reddy in 2003 and is headquartered in Hauppauge, NY. |
Pharmaceuticals: Major
|
Medispray Laboratories Pvt Ltd.
 Medispray Laboratories Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Cipla Ltd., Medispray Laboratories Pvt Ltd. is a pharmaceutical company founded in 1992. The private company is based in Goa, India. The Indian company manufactures and distributes pharmaceutical products. |
Pharmaceuticals: Major
|
Jay Precision Pharmaceuticals Pvt Ltd.
 Jay Precision Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Cipla Ltd., Jay Precision Pharmaceuticals Pvt Ltd. is a pharmaceutical company that specializes in manufacturing respiratory devices. The private company is based in Mumbai, India. The company was founded in 2012. Jay Precision Pharmaceuticals was acquired by Cipla Ltd. on February 12, 2015 for $15.42 million. |
Pharmaceuticals: Major
|
Cipla Health Ltd.
 Cipla Health Ltd. Pharmaceuticals: MajorHealth Technology Cipla Health Ltd. develops drugs. It offers products under the brand name include Nicotex, Active immuno boosters, Active women daily calcium and cofsils lozenge, Cofsils cough drops, Cofsils natural ough syrup, Nicogum and Fibocare. The company was founded in August 2015 and is headquartered in Mumbai, India. |
Pharmaceuticals: Major
|
Goldencross Pharma Pvt Ltd.
| |
Sitec Labs Ltd.
| |
Cipla Pharmaceuticals Ltd.
| |
Cipla (EU) Ltd.
 Cipla (EU) Ltd. Pharmaceuticals: MajorHealth Technology Cipla (EU) Ltd. engages in the trading and holding of marketing registrations for various pharmaceutical products. The company was founded on August 16, 2002 and is headquartered in Esher, the United Kingdom. |
Pharmaceuticals: Major
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
| % 1. Jan. | Kap. | |
|---|---|---|
| +7.98% | 13.02 Mrd. | |
| +20.91% | 43.54 Mrd. | |
| +16.96% | 21.74 Mrd. | |
| +9.05% | 13.53 Mrd. | |
| +33.80% | 11.28 Mrd. | |
| -11.05% | 6.99 Mrd. | |
| -0.05% | 6.79 Mrd. | |
| -8.87% | 5.73 Mrd. | |
| +7.71% | 5.09 Mrd. | |
| +3.49% | 4.42 Mrd. |
- Börse
- Aktien
- A0B5L5 Aktie
- Unternehmen Cipla Limited
